GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » EBITDA Margin %

Sino Biological (SZSE:301047) EBITDA Margin % : 35.84% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sino Biological EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sino Biological's EBITDA for the three months ended in Mar. 2024 was ¥54.6 Mil. Sino Biological's Revenue for the three months ended in Mar. 2024 was ¥152.3 Mil. Therefore, Sino Biological's EBITDA margin for the quarter that ended in Mar. 2024 was 35.84%.


Sino Biological EBITDA Margin % Historical Data

The historical data trend for Sino Biological's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological EBITDA Margin % Chart

Sino Biological Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 104.83 85.76 90.53 66.72 55.93

Sino Biological Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.21 46.84 43.83 32.16 35.84

Competitive Comparison of Sino Biological's EBITDA Margin %

For the Biotechnology subindustry, Sino Biological's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biological's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biological's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sino Biological's EBITDA Margin % falls into.



Sino Biological EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sino Biological's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=361.509/646.389
=55.93 %

Sino Biological's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=54.596/152.349
=35.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biological  (SZSE:301047) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Sino Biological EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sino Biological's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biological (SZSE:301047) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines